AU3804995A - Melanoma-associated protein - Google Patents

Melanoma-associated protein

Info

Publication number
AU3804995A
AU3804995A AU38049/95A AU3804995A AU3804995A AU 3804995 A AU3804995 A AU 3804995A AU 38049/95 A AU38049/95 A AU 38049/95A AU 3804995 A AU3804995 A AU 3804995A AU 3804995 A AU3804995 A AU 3804995A
Authority
AU
Australia
Prior art keywords
melanoma
associated protein
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38049/95A
Inventor
Gerd Pluschke
Peter Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU3804995A publication Critical patent/AU3804995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
AU38049/95A 1995-10-10 1995-10-10 Melanoma-associated protein Abandoned AU3804995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1995/003988 WO1997013855A1 (en) 1995-10-10 1995-10-10 Melanoma-associated protein

Publications (1)

Publication Number Publication Date
AU3804995A true AU3804995A (en) 1997-04-30

Family

ID=8166107

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38049/95A Abandoned AU3804995A (en) 1995-10-10 1995-10-10 Melanoma-associated protein

Country Status (3)

Country Link
EP (1) EP0854919A1 (en)
AU (1) AU3804995A (en)
WO (1) WO1997013855A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6736947B1 (en) 1997-12-24 2004-05-18 Kabushiki Kaisha Toshiba Sputtering target, A1 interconnection film, and electronic component
US6528481B1 (en) * 1999-02-16 2003-03-04 The Burnam Institute NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods
AU2002216296A1 (en) * 2001-01-04 2002-08-06 Cancer Research Technology Limited Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US20090169573A1 (en) * 2004-10-20 2009-07-02 Erwin Schultz T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use
US8916165B2 (en) 2004-12-15 2014-12-23 Janssen Alzheimer Immunotherapy Humanized Aβ antibodies for use in improving cognition
US8318165B2 (en) * 2006-09-08 2012-11-27 Celldex Therapeutics Inc. Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (MCSP)
JO3076B1 (en) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap Immunotherapy regimes dependent on apoe status
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
DK2403935T3 (en) 2009-03-04 2017-09-11 Univ Pennsylvania COMPOSITIONS CONTAINING ANGIOGENIC FACTORS AND METHODS OF USE THEREOF
CN102807621B (en) 2011-06-01 2016-04-13 厦门大学 Comprise the fusion rotein of diphtheria toxin non-toxic mutant CRM197 or its fragment
KR20140048292A (en) 2011-08-23 2014-04-23 로슈 글리카트 아게 Anti-mcsp antibodies
US20210308243A1 (en) * 2018-08-01 2021-10-07 The Wistar Institute Of Anatomy And Biology Optimized synthetic consensus immunogenic compositions targeting chondroitin sulfate proteoglycan 4 (cspg4)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428485B1 (en) * 1989-11-14 1996-01-10 New York Medical College Novel antiidiotypic monoclonal antibodies

Also Published As

Publication number Publication date
WO1997013855A1 (en) 1997-04-17
EP0854919A1 (en) 1998-07-29

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU6255096A (en) Pegylated modified proteins
AU4766196A (en) Anti-obesity proteins
AU4774496A (en) Anti-obesity proteins
AU4862096A (en) Anti-obesity proteins
AU4705196A (en) Anti-obesity proteins
AU4774696A (en) Anti-obesity proteins
AU4766096A (en) Anti-obesity proteins
AU4922497A (en) Interleukin-18-receptor proteins
AU6721696A (en) Cd44-like protein
AU5181296A (en) Anti-obesity proteins
AU3804995A (en) Melanoma-associated protein
AU6489996A (en) Methods for increasing protein expression
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU7520396A (en) Abl-interactor protein
AU5284296A (en) Immune-evading proteins
AU6000698A (en) Proteins
AU6275098A (en) Novel h-rev 107-like protein
AU7423796A (en) Novel stress proteins
AU6890696A (en) Peptide derivatives
AU6945596A (en) Cosmetic
AU6153396A (en) E6ap-binding proteins
GB9519865D0 (en) Protein
AU6890596A (en) Peptide derivatives